# name
Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD

# metadata.dc.description.abstract[].value
In the difficult-to-treat subgroup of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid aspirin-exacerbated respiratory disease, dupilumab significantly improved CRSwNP disease outcomes, along with asthma control and lung function. This is preliminary evidence of the effect of dupilumab in patients with CRSwNP and comorbid aspirin- exacerbated respiratory disease.

# metadata.dc.relation.ispartof[].value
The Journal of Allergy and Clinical Immunology: In Practice, 2019, vol. 7, num. 7, p. 2462-2465.e1

# metadata.dc.rights[].value
cc-by-nc-nd (c) American Academy of Allergy, Asthma & Immunology, 2019

# metadata.dc.source[].value
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

# metadata.dc.title[].value
Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD